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Surreptitious Ingestion of Oral Anticoagulants
T h o m a s H . G r e i d a n u s , M . D . , * E l l i s J. V a n Slyck, M . D . , * *
and R a y m o n d W . M o n t o , M . D . * *

Hypoprothrombinemia
secondary to surreptitious ingestion of coumarin or indanedione anticoagulants may be a difficult diagnosis for the unsuspecting
physician. Four such case reports are presented. The disease should be suspected if the
prothrombin time is markedly elevated and the individual is associated with the
medical profession or has had previous treatment with oral anticoagulants.
The
diagnosis is confirmed by finding a deficiency in Factors II (prothrombin),
VII,
IX, and X and the presence of the coumarin or indanedione anticoagulant in the
blood. The motive generally is that of gaining attention rather than
committing
suicide. Liver disease. Vitamin K deficiency states and accidental ingestion of oral
anticoagulants are the chief disorders to be considered in the differential diagnosis.
Specific assays for the oral anticoagulants are indicated before assuming a rarer
etiology for the hemorrhagic
syndrome.

The oral anticoagulants, coumarin
and indanedione derivatives, are commonly used for the treatment of thromboembolic disease. Since 1951, occasional reports have appeared concerning surreptitious ingestion of oral anticoagulants as a cause of hypoprothrombinemia.'Recent discussion on this
subject by Bowie and associates^ and
by O'Reilly and Aggeler-' has emphasized certain diagnostic features. In addition, they made the observation that
this particular form of malingering generally occurs in individuals closely associated with the medical profession or
who have had previous treatment with
oral anticoagulants.

clan. Our purpose is to emphasize the
characteristic features, the management of the patient, the mechanism of
competitive inhibition between oral
anticoagulants and Vitamin K, and to
discuss the psychodynamics of patient
motivation.
Materials and Methods
Coagulation studies of four patients
are presented in Table I . The prothrombin time and plasma clotting time were
measured by the methods described by
Quick. The partial thromboplastin time
was determined as described by Rodman, et al." Prothrombin consumption
was performed as described by Sussman, et al,'^ the two-stage prothrombin
assay by the method of Ware and Seegers,* the thromboplastin generation
test by the method of Biggs and Douglas,^ and the prothrombin and proconvertin test by the method of Owren and
Aas.'" The concentration of warfarin
in plasma was measured as described
by O'Reilly, Aggeler and associates,'^

Hypoprothrombinemia on the basis
of surreptitious ingestion of coumarin
or indanedione anticoagulants may present a diflficult diagnostic and therapeutic problem for the unsuspecting physi* Now in private practice in Edmonton, A l berta, Canada
** Division of Hematology, Department of
Medicine
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TABLE I
CASE 1
Bleeding time
(in minutes)
Lee-White clotting
(time in minutes)
Plasma clotting time
(normal 80-12(1 sec.)
Prothrombin time
(in seconds)
a) Control
b) Patient
Partial thromboplastin time
(in seconds)
a) Control
b) Patient
c) 1 part patient
plasma plus 1
part normal plasma
Prothrombin consumption
(normal greater than 25 sec.)

CASE II

CASE III

CASE IV

14&19

m & 18^

m & 16^

4!4
11^ & 14
150

190

300

165

12
62

15
100

15
185

12
58

66
over 560

58
no end pt.

58
270

65

100

145

93

95

42

100

100

100

100

7

13

12

20

7

0

Factor II (%of normal)

6.5

0

P & P test of Owren for
Factor Vll & X(%of normal)

8.5

5

Russell viper venom & cephalin
test for Factor X (% of normal)
Plasma Coumadin in mg./L.

3
9.8

8.1

Two stage prothrombin assay
(%of normal)
a) Control
b) Patient plasma with
Factor V
c) Patient plasma without Factor V

19
12

19

7

Coagulation studies in four cases of surreptitious ingestion of oral anticoagulants.

and the concentration of bishydroxycoimiarin in plasma was measvured as
described by Axelrod, Cooper and
Brodie.12
Case Reports

evaluation of abnormal bleeding and refractory hypoprothrombinemia. In September,
1964, the patient developed thrombophlebitis
following a fracture of the left leg. Sodium
warfarin (Coumadin) therapy was initiated
and continued until March, 1965. Recurrent
thrombophlebitis necessitated reinstitution of
warfarin in April, 1965. Subsequently, during an episode of abdominal pain and hematuria, the prothrombin time was found to

Case I
The patient, aged 60 years, a white housewife and school teacher, was referred for
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be 19%. It returned toward the normal
range following daily intravenous injections
of phytonadione (Aquamephyton). Later,
however, the prothrombin time was again
found to be elevated, but failed to return to
normal with daily oral and weekly intravenous Vitamin K.
The patient was studied at a university
hospital in another state. The only abnormalities found were a prothrombin time of
10%, a clotting time of 28 minutes, and a
sulfobromophthalein retention of 12.5% in
45 minutes. The bleeding time was normal.
An opinion was rendered that chronic liver
disease accounted for her lowered prothrombin levels.
The patient continued to cause her family
doctor serious concern. She appeared to respond only to intravenous Vitamin K and
accordingly received phytonadione 40 mgs
once a week. Without this therapy, hematuria and ecchymoses would occur. The
patient then developed local skin reactions
at the sites of the Vitamin K injections and
her physician feared an imminent systemic
reaction of the anaphylactoid type.
One year from the onset of her illness, she
was admitted to the Henry Ford hospital on
May 22, 1966. Her only medication at that
time was 75 units of Lente insulin daily. She
was a well-respected third grade school
teacher, who had been seemingly happily
married to a truant officer in the same school
system for 37 years.
On examination, the patient was a very
pleasant, slightly obese, motherly type of
woman who appeared younger than her age.
A fading ecchymosis was noted on the buttocks. Physical examination was otherwise
unremarkable.
The routine laboratory examinations were
normal, but the sulfobromophthalein test
showed 9% retention in 45 minutes. The coagulation studies are recorded in Table I .
There was a deficiency in Factors I I (prothrombin), VII, X, and a probable deficiency
in Factor IX (a test specifically for Factor
IX was not performed). Significantly, the
plasma warfarin level was found to be 9.8
mg/litre.
The diagnosis of coumarin toxicity was,
therefore, established and her local physician
was asked to contact her druggist. Her physician was surprised to find out that she had
purchased refills of 5 mg warfarin tablets
on at least five occasions during the previous
year and as recently as two weeks before the
present hospital admission. Consequently,
her hospital room was searched in her absence, and warfarin 5 mgs was found

wrapped in aluminum foil in her suitcase.
These were left in place except for two tablets taken as "evidence."
On confrontation (by a psychiatrist), the
patient denied self-medication, even though
medicine had been found in her suitcase.
However, several hours later, she stated to
the medical resident, " I thought they were
diet pills. I wasn't taking them intentionally."
She then relinquished her supply of warfarin
and vowed that she would never make the
"mistake" again. The patient was permitted
this face-saving explanation.
The blood warfarin levels subsequently decreased at a rate consistent with normal in
vivo degradation of the drug. Phytonadione
was administered in a dose of 5 mg orally
twice a day. Two days later her prothrombin
time was 15 seconds. She returned to her
community where she became free of hemorrhagic phenomena.
Case II
The patient was a 30-year-old, single
white female who was a registered nurse.
Nine years previously, while in training, she
developed idiopathic thrombocytopenic purpura. Symptoms were menorrhagia, metrorrhagia and easy bruisability. She received
three whole blood transfusions and was
treated with corticosteroids for one year.
Symptoms subsided except for a moderate
degree of menorrhagia.
In January, 1965, the patient sought medical attention for a recurrence of bruising
and a worsening of menorrhagia. Between
April and November, 1965, she was admitted
to another hospital three times by her local
physician. Her prothrombin time was as
high as 102 seconds, but on each occasion
the administration of intramuscular phytonadione was followed by a return of the
prothrombin time to normal within 24 hours.
In late November, 1965, she was referred
to Henry Ford Hospital for investigation of
possible liver disease or malabsorption of
Vitamin K. She had always been obese,
weighing 250 pounds ten years previously
and 290 pounds on admission. She had twice
made half-hearted attempts to reduce, but
stated that now she did not really care.
On physical examination, in addition to
marked obesity, several large ecchymoses
were seen on the extremities and abdomen.
The routine laboratory values and liver function profile were normal. However, the prothrombin time was 54 seconds the night of
admission, 103 seconds the following day
and reached a peak of 227 seconds on the
fourth day of hospitalization. During this
time she was given oral phytonadione 5 mg
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three times a day. Phytonadione 72 mg was
then given intravenously. The prothrombin
time was 134 seconds just prior to giving the
intravenous Vitamin K, and did not change
significantly over the following days. The
coagulation studies are recorded in Table I .
Direct determination of the presence of an
oral anticoagulant in the blood or urine was
not performed.
The failure to observe a favorable response of the prothrombin time to administered Vitamin K was interpreted as indirect
evidence that the patient had taken a massive
dose of a coumarin drug just before her
admission to the hospital. It was also likely
that she was continuing to consume the drug
while under our observation. The patient
hotly denied this on confrontation. Nonetheless, she was informed that she could keep
from getting into difficulty by making certain that she avoided ingestion of this type
of drug. Her cryptic reply was, "Well, that is
easier said than done." Following discharge
from the hospital she was admitted to another hospital two months later with the
same problem, and eventually underwent a
hysterectomy.

years, was admitted to Henry Ford Hospital
March, 1968, with hematuria. The hematuria began three months earlier and initially
cleared after treatment with sulfamethoxazole. Subsequently, the hematuria recurred
and was associated with mild dysuria and
frequency. Urine culture, excretory urogram,
and cystoscopy were normal. Menstrual flow
just prior to admission was unusually heavy.
Because coagulation studies were suggestive
of ingestion of oral anticoagulants, the
patient was admitted to the hospital for further clinical and psychiatric investigation.
Her past history revealed symptomatology
of recurrent "cystitis" since childhood. Her
mother stated that her daughter always had
a "weak bladder" and frequently sought
medical care. Her local physician believed
her symptomatology to be "functional" and
warned against frequent medical contacts.
Repeat urologic examinations over the years
failed to reveal objective evidence to support her complaints except for two positive
urine cultures which had been obtained 10
months and 26 months prior to this admission. The patient was considered to be an excellent student nurse who was due to graduate in three months. She was shy and rarely
accepted dates.
Physical examination was unremarkable
except for several ecchymoses on the arms
and legs. Laboratory studies were normal except for a prothrombin time of 58 seconds.
Coagulation studies are shown in Table I .
The plasma warfarin level was 8.1 mg/litre.
A search of the patient, her hospital room,
and her nursing school quarters failed to reveal warfarin. When confronted with our
knowledge of her warfarin ingestion, the
patient initially denied this and failed to show
any emotional response. Three days later the
patient confessed to warfarin ingestion. After
discharge from the hospital she was to be followed by a psychiatrist with regard to emotional factors.

Case III
The patient, aged 37 years, a single female
housekeeper, was admitted July 23, 1958,
with menorrhagia, melena, weakness, epistaxis, ecchymoses, and sore throat. She was
acutely ill with marked pallor, a large hematoma in the pharynx, tender cervical and
inguinal lymphadenopathy, diffuse abdominal
tenderness and guarding, and ecchymoses
confined mainly to the legs. The admission
laboratory data included a hemoglobin of
5.0 gm/100 ml and a platelet count of 175,000/ cu mm. The prothrombin time was 185
seconds (control 15 seconds). Subsequent
coagulation studies are shown in Table I .
Interrogation of the elderly couple for
whom the patient was a housekeeper, revealed that the man was receiving phenprocoumon (Marcumar) for the treatment of
arteriosclerotic heart disease. When asked to
check his anticoagulant supply, he noted that
much of his phenprocoumon was missing.
Phytonadione 50 mg was given intravenously
to the patient as well as several units of
whole blood. Within 24 hours the prothrombin time was 17 seconds (control 15 seconds).
Subsequently, she admitted ingesting the
anticoagulant. In this particular patient, this
action was believed possibly to have represented an attempt to commit suicide.

Discussion

Hypoprothrombinemia is the result of
a deficiency of one or more of those
factors involved in the one-stage prothrombin time. These are Factors I I
(prothrombin), V, VII, and X. However Coumarin and the indanedione anticoagulants depress Factors I I , V I I ,
IX, and X and differ from one another
only in their duration of action. Factor

Case IV
A white female student nurse, age 20
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V I I is depressed most rapidly, followed
in 24 to 48 hours by depression of Factors I I , I X , and X. The action of these
drugs occurs in the liver where they
competitively interfere with Vitamin K
synthesis, which thereby blocks the latter's contribution of a common protein
precursor for the synthesis of Factors
I I , V I I , IX, and X. In gross overdosage
with coumarin, massive doses of Vitamin K cannot restore the coagulation
defect, suggesting that the relationship
cannot be regarded as a simple competitive system.
Administration of Vitamin K doss
not alter the rate of disappearance of
coumarin from the blood stream, although the prothrombin time may return to normal. This observation also
emphasizes the competitive inhibition
of coumarin by Vitamin K, the excess
Vitamin K permitting normal synthesis
of the deficient factors. Findings in our
first case demonstrate this point. In
Figure I , it is noted that two days following discontinuation of the warfarin
(Coumadin), the plasma warfarin was
at an elevated level, but the prothrombin time was almost normal. When a
patient has ingested a large amount of
PROTHROMBIN
T I M E - SEC.

oral anticoagulant, 50-100 mgs of
Vitamin K intravenously daily for several days is required to correct the prothrombin time. The patient in our second case was thought to have ingested
such a large amount of an oral anticoagulant that 75 mgm of Vitamin K
was not sufficient to influence the prothrombin time.
A related consideration requires emphasis. The coumarin and indanedione
drugs, though measurably present in
the plasma, are not circulating anticoagulants since they exert theh activity
only in the liver and have no eflect on
coagulation in vitro. True circulating
anticoagulants either block reactions
between clotting factors (inhibitors) or
destroy factors (inactivators). A screening test for circulating anticoagulants
may be performed by adding one part
normal plasma to one part patient's
plasma and observing the effect on the
plasma clotting time or partial thromboplastin time. If a circulating anticoagulant is present, the coagulation defect will persist. In our first two cases,
the addition of normal plasma largely
corrected the partial thromboplastin
time, indicating that a true circulating
anticoagulant was not present.

e LOGO
WARFARIN

Differential Diagnosis

ZPM

aA.M

Congenital deficiency of Factors I I ,
V, V I I , or X are rare. Acquired hypoprothrombinemia occurs primarily as a
result of (1) liver disease, (2) Vitamin
K deficiency, or (3) ingestion of an oral
anticoagulant.
Parenchymal liver disease produces
deficiences of the Vitamin K - dependent clotting factors, but in addition,
Factor V is often depressed. Sherlock
et al^^ found that the extent of par-

SAM.

DAYS
COUMADIN

>IOmg q.d.

t

1

VITAMIN'
10 mg qa.
orally

Figure 1

Degradation curve for plasma warfarin demonstrating practically normal prothrombin
time on the seventh day while plasma warfarin is still markedly elevated.
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enchymal liver damage could be adequately assessed by the prothrombin
time, bUhubin, serum albumin, and
the clinical picture. Pertinently, it was
noted that their patients with known
severe liver disease, who had a prothrombin time of 1.5 times normal or
longer, not correctable by parenteral
Vitamin K therapy, died during that
hospital stay. Therefore, a very long
prothrombin time as an isolated finding
will tend to eliminate parenchymal
liver disease from the differential diagnosis. Furthermore, in parenchymal
liver disease there is little or no response to Vitamin K parenterally. A
good response to parenteral Vitamin
K is generally observed within 24hours
in Vitamin K deficiency due to other
causes.

ticoagulant should be obtained when
a markedly prolonged prothrombin
time is unexpectedly encountered.
Drugs which have a similar but
weaker effect than coumarin on clotting factors include salicylates, phenylbutazone, quinidine^* and heparin.
Several other drugs, although having
no anticoagulant activity themselves,
potentiate the action of the oral anticoagulants. Phenyramidol hydrochloride and clofibrate are such drugs.i''
In the presence of a naturally occurring circulating anticoagulant the prothrombin time is prolonged in almost
every instance, sometimes to a marked
degree. This is most commonly encountered in association with systemic lupus
erythematosus, and can be recognized
by failure to correct with added normal
plasma (vide supra). Intravascular coagulation and fibrinolysis deplete the
blood of prothrombin but the associated depression of Factors V and V I I I ,
and generally of platelets, removes consideration of coumarin drug ingestion
as a cause.

Dietary Vitamin K deficiency occurs
as part of a complex of deficiencies in
generalized malnutrition. Deficiency of
Vitamin K also occurs when bile fails
to reach the intestine (common bile
duct obstruction or fistula), if intestinal transit is increased (prolonged
diarrhea), and if the absorptive function of the intestinal mucosa is impaired, as in sprue. In addition, prolonged treatment with certain antimicrobial drugs may result in a lack of
Vitamin K-producing bacteria in the
gut with consequent Vitamin K deficiency.
Accidental ingestion of anticoagulants may occur, producing a marked
elevation of the prothrombin time. This
can be confirmed by examining all
medications being taken by the patient.
In recent months we have encountered
two patients who received oral anticoagulants by accident. 1* In each instance a severe hemorrhagic disorder
resulted. A serum assay for an oral an-

Psycho-Sociological Considerations

Relatively little is noted in the literature as to the psychodynamics of the
patients with surreptitious ingestion of
coumarin. These individuals usually
appear to be intelligent and of average
or above average socio-economic
status. Previous experience with anticoagulants or some association with
the medical profession is common in
this group. Of the 36 cases (including
our own) that appear in the literature,
80% are female and 60% of all cases
are registered nurses. Suspect individuals are those who have ready access
to the drugs, such as pharmacists,
nurses, doctors and orderlies.
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None of these 36 patients underwent extensive psychiatric evaluation.
Attempts at psychiatric evaluations
were made in two of our patients, but
in both instances the patient viewed the
psychiatrist as a detective, making it
impossible to interview the patient in
depth. Our fourth case, the student
nurse, was of particular interest. This
patient had focused the attention of her
parents and doctors on symptoms from
her urinary tract since childhood. One
doctor referred to her symptoms as being "ninety per cent functional." The
patient may well have felt that she was
being ignored by her doctor and succeeded in startling him when she presented with hematuria.

lying neurotic or psychotic process is
likely. These patients could be considered to have a form of malingering.
Our third patient was presumably attempting suicide and, if so, was not
truly malingering.
The suggested approach is to confront the patient in a non-judgmental
fashion. It is the physician's responsibility to try to understand the patient's
difficulty and to communicate to the
patient his wish to help. The physician
must inquire into the stresses that led
the patient into this unusual behavior.
Frequently, if not usually, the patient
refuses the invitation to explore the situation further because of his resentment and guilt. However, the groundwork may be laid for the patient subsequently to come to grips with his
basic problems in a more constructive
fashion. On the other hand, the patient
may continue the surreptitious ingestion of anticoagulants or he may substitute another drug with possible
greater hazard to health.

There can be considerable speculation as to why an individual would surreptitiously ingest a relatively dangerous drug. It would appear that the
motive for bringing this bleeding disorder upon one's self would be to gain
greater attention from family, friends,
doctors, and the community. An under-
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